甲状腺癌的淋巴结转移：预后意义及处理
Nodal metastases in thyroid cancer: prognostic implications and management.
作者信息
Wang Laura Y, Ganly Ian
机构信息
Department of Surgery, Head & Neck Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
出版信息
Future Oncol. 2016 Apr;12(7):981-94. doi: 10.2217/fon.16.10. Epub 2016 Mar 7.
Abstract
The significance of cervical lymph node metastases in differentiated thyroid cancer has been controversial and continues to evolve. Current staging systems consider nodal metastases to confer a poorer prognosis, particularly in older patients. Increasingly, the literature suggests that characteristics of the metastatic lymph nodes such as size and number are also prognostic. There is a growing trend toward less aggressive treatment of low-volume nodal disease. The aim of this review is to summarize the current literature and discuss prognostic and management implications of lymph node metastases in differentiated thyroid cancer.
摘要
分化型甲状腺癌中颈部淋巴结转移的意义一直存在争议且仍在不断演变。目前的分期系统认为淋巴结转移预示着较差的预后，尤其是在老年患者中。越来越多的文献表明，转移淋巴结的特征如大小和数量也具有预后价值。对于低负荷淋巴结疾病，采用侵袭性较小的治疗方法的趋势日益明显。本综述的目的是总结当前文献，并讨论分化型甲状腺癌中淋巴结转移的预后及管理意义。
相似文献
1
Nodal metastases in thyroid cancer: prognostic implications and management.甲状腺癌的淋巴结转移：预后意义及处理
Future Oncol. 2016 Apr;12(7):981-94. doi: 10.2217/fon.16.10. Epub 2016 Mar 7.
2
Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.甲状腺乳头状癌区域淋巴结转移的结外扩展的预后意义
Head Neck. 2015 Sep;37(9):1336-43. doi: 10.1002/hed.23747. Epub 2014 Oct 29.
3
Prospective management of nodal metastases in differentiated thyroid cancer.分化型甲状腺癌区域淋巴结转移的前瞻性管理
Am J Surg. 1991 Oct;162(4):353-6. doi: 10.1016/0002-9610(91)90147-6.
4
Predictive value of nodal metastases on local recurrence in the management of differentiated thyroid cancer. Retrospective clinical study.分化型甲状腺癌治疗中淋巴结转移对局部复发的预测价值。回顾性临床研究。
BMC Surg. 2013;13 Suppl 2(Suppl 2):S3. doi: 10.1186/1471-2482-13-S2-S3. Epub 2013 Oct 8.
5
The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension.甲状腺乳头状癌淋巴结转移的预后意义可以根据转移淋巴结的大小和数量，以及是否存在淋巴结外侵犯进行分层。
Thyroid. 2012 Nov;22(11):1144-52. doi: 10.1089/thy.2012.0043. Epub 2012 Oct 19.
6
Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension.具有颈部淋巴结转移的甲状腺乳头状癌可以通过致癌 BRAF、淋巴结转移的数量和淋巴结外侵犯进行分层，以达到具有临床意义的预后分类。
Thyroid. 2012 Jun;22(6):575-84. doi: 10.1089/thy.2011.0431. Epub 2012 Apr 3.
7
Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.甲状腺癌的管理：英国国家多学科指南
J Laryngol Otol. 2016 May;130(S2):S150-S160. doi: 10.1017/S0022215116000578.
8
Clinicopathological pattern of lymph node recurrence of papillary thyroid cancer. Implications for surgery.甲状腺乳头状癌淋巴结复发的临床病理模式。对手术的影响。
Int J Surg. 2014;12 Suppl 1:S194-7. doi: 10.1016/j.ijsu.2014.05.010. Epub 2014 May 23.
9
Management of Nodal Disease in Thyroid Cancer.甲状腺癌的淋巴结疾病管理。
Surg Clin North Am. 2019 Aug;99(4):611-632. doi: 10.1016/j.suc.2019.04.004.
10
Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer.术后¹²⁴I-NaI-PET/CT诊断为放射性碘敏感的局部淋巴结转移灶手术清扫不完全对甲状腺乳头状癌患者的预后影响
Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):1988-94. doi: 10.1007/s00259-016-3400-y. Epub 2016 Apr 27.
引用本文的文献
1
A Model Predicting Occult Metastases in Lateral Lymph Nodes in pN1a Stage Papillary Thyroid Cancer.预测pN1a期乳头状甲状腺癌侧方淋巴结隐匿性转移的模型
Int J Gen Med. 2025 Aug 6;18:4279-4290. doi: 10.2147/IJGM.S528876. eCollection 2025.
2
Correlation between preoperative uric acid levels and lymph node metastases in patients with papillary thyroid cancer: a retrospective study.甲状腺乳头状癌患者术前尿酸水平与淋巴结转移的相关性：一项回顾性研究
PeerJ. 2025 Jul 10;13:e19410. doi: 10.7717/peerj.19410. eCollection 2025.
3
Multi-omics analysis unveils dysregulation of the tumor immune microenvironment and development of a machine learning-based multi-gene classifier for predicting lateral lymph node metastasis in papillary thyroid carcinoma.多组学分析揭示了甲状腺乳头状癌肿瘤免疫微环境的失调以及基于机器学习的多基因分类器的开发，用于预测侧方淋巴结转移。
Endocrine. 2025 Jun 15. doi: 10.1007/s12020-025-04308-6.
4
Utility of Lymph Node Ratio in Predicting Biochemical Incomplete Clinical Response in Patients with Papillary Ca thyroid with Positive Neck Node.淋巴结比率在预测颈部淋巴结阳性的甲状腺乳头状癌患者生化不完全临床反应中的应用
Indian J Otolaryngol Head Neck Surg. 2024 Oct;76(5):4043-4049. doi: 10.1007/s12070-024-04777-7. Epub 2024 Jun 6.
5
Survival in Thyroid Cancer in Sweden From 1999 To 2018.1999年至2018年瑞典甲状腺癌患者的生存率
Clin Epidemiol. 2024 Oct 2;16:659-671. doi: 10.2147/CLEP.S467874. eCollection 2024.
6
The Role of Risk Factors for the Progression of Patients with T1b-T2 Papillary Thyroid Carcinoma (PC) during Long-Term Follow-Up.T1b-T2期甲状腺乳头状癌（PC）患者长期随访过程中进展的危险因素的作用
J Clin Med. 2024 Sep 11;13(18):5373. doi: 10.3390/jcm13185373.
7
European Society of Endocrine Surgeons (ESES) consensus statement on advanced thyroid cancer: definitions and management.欧洲内分泌外科学会（ESES）关于晚期甲状腺癌的共识声明：定义与管理
Br J Surg. 2024 Aug 2;111(8). doi: 10.1093/bjs/znae199.
8
Clinical-Pathological Features of Thyroid Neoplasms in Young Patients Diagnosed in a Single Center.单中心诊断的年轻患者甲状腺肿瘤的临床病理特征
Life (Basel). 2024 May 28;14(6):696. doi: 10.3390/life14060696.
9
A nomogram based on clinicopathological and ultrasound characteristics to predict central neck lymph node metastases in papillary thyroid cancer.基于临床病理和超声特征的列线图预测甲状腺乳头状癌中央颈部淋巴结转移。
Front Endocrinol (Lausanne). 2024 Feb 12;14:1267494. doi: 10.3389/fendo.2023.1267494. eCollection 2023.
10
Asiaticoside Down-Regulates HIF-1α to Inhibit Proliferation, Migration, and Angiogenesis in Thyroid Cancer Cells.积雪草苷通过下调 HIF-1α 抑制甲状腺癌细胞的增殖、迁移和血管生成。
Balkan Med J. 2024 Jan 3;41(1):23-29. doi: 10.4274/balkanmedj.galenos.2023.2023-7-123. Epub 2023 Dec 4.
本文引用的文献
1
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南：美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
2
Cost-effectiveness analysis of papillary thyroid cancer surveillance.甲状腺乳头状癌监测的成本效益分析
Cancer. 2015 Dec 1;121(23):4132-40. doi: 10.1002/cncr.29633. Epub 2015 Aug 17.
3
Role of RAI in the management of incidental N1a disease in papillary thyroid cancer.放射性碘在甲状腺乳头状癌偶发N1a期疾病管理中的作用
Clin Endocrinol (Oxf). 2016 Feb;84(2):292-295. doi: 10.1111/cen.12828. Epub 2015 Jul 3.
4
Lateral Neck Lymph Node Characteristics Prognostic of Outcome in Patients with Clinically Evident N1b Papillary Thyroid Cancer.侧颈部淋巴结特征对临床确诊为N1b期乳头状甲状腺癌患者预后的预测价值
Ann Surg Oncol. 2015 Oct;22(11):3530-6. doi: 10.1245/s10434-015-4398-2. Epub 2015 Feb 10.
5
Integrated genomic characterization of papillary thyroid carcinoma.甲状腺乳头状癌的综合基因组特征分析
Cell. 2014 Oct 23;159(3):676-90. doi: 10.1016/j.cell.2014.09.050.
6
Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.BRAF V600E突变与甲状腺乳头状癌复发之间的关联。
J Clin Oncol. 2015 Jan 1;33(1):42-50. doi: 10.1200/JCO.2014.56.8253. Epub 2014 Oct 20.
7
Central lymph node characteristics predictive of outcome in patients with differentiated thyroid cancer.分化型甲状腺癌患者中央淋巴结特征对预后的预测作用
Thyroid. 2014 Dec;24(12):1790-5. doi: 10.1089/thy.2014.0256.
8
Prognostic value of genetic mutations in thyroid cancer: a meta-analysis.甲状腺癌基因突变的预后价值：一项荟萃分析。
Thyroid. 2015 Jan;25(1):63-70. doi: 10.1089/thy.2014.0241.
9
Preoperative neck ultrasound in clinical node-negative differentiated thyroid cancer.术前颈部超声在临床隐匿性分化型甲状腺癌中的应用。
J Clin Endocrinol Metab. 2014 Oct;99(10):3686-93. doi: 10.1210/jc.2014-1681. Epub 2014 Jul 25.
10
Guidelines for the management of thyroid cancer.甲状腺癌管理指南。
Clin Endocrinol (Oxf). 2014 Jul;81 Suppl 1:1-122. doi: 10.1111/cen.12515.
Zotero 插件